BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 24366862)

  • 1. Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration.
    Asuni AA; Gray B; Bailey J; Skipp P; Perry VH; O'Connor V
    J Biol Chem; 2014 Feb; 289(7):4532-45. PubMed ID: 24366862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Hippocampal Synaptic Loss Precedes Neuronal Loss and Associates with Early Behavioural Deficits in Three Distinct Strains of Prion Disease.
    Hilton KJ; Cunningham C; Reynolds RA; Perry VH
    PLoS One; 2013; 8(6):e68062. PubMed ID: 23840812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and Environment Influences on Mouse Prion Disease Progression: Behavioral Changes and Morphometry and Stereology of Hippocampal Astrocytes.
    Bento-Torres J; Sobral LL; Reis RR; de Oliveira RB; Anthony DC; Vasconcelos PF; Picanço Diniz CW
    Oxid Med Cell Longev; 2017; 2017():4504925. PubMed ID: 28243355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of the presynaptic co-chaperone cysteine string protein alpha (CSPα) does not exacerbate experimentally-induced ME7 prion disease.
    Davies MJ; Cooper M; Perry VH; O'Connor V
    Neurosci Lett; 2015 Mar; 589():138-43. PubMed ID: 25623034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism.
    Makarava N; Chang JC; Molesworth K; Baskakov IV
    Neurobiol Dis; 2020 Apr; 137():104783. PubMed ID: 32001329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change in tau phosphorylation associated with neurodegeneration in the ME7 model of prion disease.
    Asuni AA; Perry VH; O'Connor V
    Biochem Soc Trans; 2010 Apr; 38(2):545-51. PubMed ID: 20298219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of glial fibrillary acidic protein fragments and mu-calpain activation within the hippocampus of prion-infected mice.
    Gray BC; Skipp P; O'Connor VM; Perry VH
    Biochem Soc Trans; 2006 Feb; 34(Pt 1):51-4. PubMed ID: 16417481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection.
    Carroll JA; Race B; Williams K; Striebel J; Chesebro B
    Mol Brain; 2020 May; 13(1):71. PubMed ID: 32381108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An astrocyte cell line that differentially propagates murine prions.
    Tahir W; Abdulrahman B; Abdelaziz DH; Thapa S; Walia R; Schätzl HM
    J Biol Chem; 2020 Aug; 295(33):11572-11583. PubMed ID: 32561641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology.
    Gray BC; Siskova Z; Perry VH; O'Connor V
    Neurobiol Dis; 2009 Jul; 35(1):63-74. PubMed ID: 19362593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of Perineuronal Net in ME7 Prion Disease.
    Franklin SL; Love S; Greene JR; Betmouni S
    J Neuropathol Exp Neurol; 2008 Mar; 67(3):189-99. PubMed ID: 18344910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Cell Model for Investigating Prion Strain Selection and Adaptation.
    Philiastides A; Ribes JM; Yip DC; Schmidt C; Benilova I; Klöhn PC
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31546723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The degree of astrocyte activation is predictive of the incubation time to prion disease.
    Makarava N; Mychko O; Chang JC; Molesworth K; Baskakov IV
    Acta Neuropathol Commun; 2021 May; 9(1):87. PubMed ID: 33980286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice.
    Majer A; Medina SJ; Niu Y; Abrenica B; Manguiat KJ; Frost KL; Philipson CS; Sorensen DL; Booth SA
    PLoS Pathog; 2012; 8(11):e1003002. PubMed ID: 23144617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7-model of prion disease.
    Asuni AA; Hilton K; Siskova Z; Lunnon K; Reynolds R; Perry VH; O'Connor V
    Neuroscience; 2010 Feb; 165(3):662-74. PubMed ID: 19879926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Glial Cells in Neurobiology and Prion Neuropathology.
    Hay A; Popichak K; Moreno J; Zabel M
    Cells; 2024 May; 13(10):. PubMed ID: 38786054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement 3
    Hartmann K; Sepulveda-Falla D; Rose IVL; Madore C; Muth C; Matschke J; Butovsky O; Liddelow S; Glatzel M; Krasemann S
    Acta Neuropathol Commun; 2019 May; 7(1):83. PubMed ID: 31118110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trazodone rescues dysregulated synaptic and mitochondrial nascent proteomes in prion neurodegeneration.
    Albert-Gasco H; Smith HL; Alvarez-Castelao B; Swinden D; Halliday M; Janaki-Raman S; Butcher AJ; Mallucci GR
    Brain; 2024 Feb; 147(2):649-664. PubMed ID: 37703312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astrocytes Are Primed by Chronic Neurodegeneration to Produce Exaggerated Chemokine and Cell Infiltration Responses to Acute Stimulation with the Cytokines IL-1β and TNF-α.
    Hennessy E; Griffin ÉW; Cunningham C
    J Neurosci; 2015 Jun; 35(22):8411-22. PubMed ID: 26041910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease.
    Cunningham C; Deacon R; Wells H; Boche D; Waters S; Diniz CP; Scott H; Rawlins JN; Perry VH
    Eur J Neurosci; 2003 May; 17(10):2147-55. PubMed ID: 12786981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.